Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
6.59
+0.41 (6.63%)
At close: Nov 6, 2026, 4:00 PM EST
6.72
+0.13 (1.97%)
After-hours: Nov 6, 2026, 7:30 PM EST
Solid Biosciences Employees
Solid Biosciences had 121 employees as of December 31, 2025. The number of employees increased by 21 or 21.00% compared to the previous year. That makes Solid Biosciences the 30,279th largest employer in the world and 3,868th in the United States.
Employees
121
Change (1Y)
21
Growth (1Y)
21.00%
Revenue / Employee
n/a
Profits / Employee
-$1,779,099
Market Cap
735.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 121 | 21 | 21.00% |
| Dec 31, 2024 | 100 | 12 | 13.64% |
| Dec 31, 2023 | 88 | 1 | 1.15% |
| Dec 31, 2022 | 87 | -17 | -16.35% |
| Dec 31, 2021 | 104 | 34 | 48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Wave Life Sciences | 317 |
| Kura Oncology | 260 |
| Geron | 258 |
| 4D Molecular Therapeutics | 196 |
| Aura Biosciences | 113 |
| Candel Therapeutics | 55 |
| Design Therapeutics | 55 |
| Achieve Life Sciences | 28 |
SLDB News
- 2 days ago - Solid Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference - GlobeNewsWire
- 3 days ago - Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 days ago - Solid Biosciences Quarterly report: Q3 2026 - Filings
- 3 days ago - Solid Biosciences Earnings release: Q3 2026 - Filings
- 12 days ago - Solid Biosciences granted Orphan designation for SGT-212 - TheFly
- 12 days ago - Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich's Ataxia - GlobeNewsWire
- 18 days ago - Solid Biosciences to Present Research Across Gene Therapy Development, Delivery and Manufacturing at ESGCT 2026 - GlobeNewsWire
- 24 days ago - Solid Biosciences initiated with a Buy at UBS - TheFly